October 30, 2025

Sydnexis Receives Complete Response Letter From FDA Regarding Myopia Treatment

The NDA for SYD-101 was supported by the results of the phase 3 STAR trial, which evaluated more than 800 children aged 3 to 14 at treatment initiation.

Optometric Management

October 29, 2025

Updated Myopia Control Measures for Kids

A comprehensive review highlights outdoor time, low-dose atropine and red-light therapy.

Contact Lens Spectrum

October 11, 2025

2025 American Academy of Optometry Annual Meeting

Find all of Optometric Management's coverage from the show below

Conexiant

October 01, 2025

Navigating Orthokeratology Through Imaging

Explore how advanced imaging techniques enhance orthokeratology lens fitting for effective myopia management, as discussed by Dr. Matthew McGee.

Contact Lens Spectrum

October 06, 2025

Nearly 600 Advocates Unite in Washington for AOA on Capitol Hill 2025

The event provided for a unified, pro-patient message to policymakers

Optometric Management

December 01, 2020

MYOPIA MATTERS

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters

June 01, 2023

CLINICAL Myopia Management

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

September 01, 2023

Tips from the Issue

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management